Overall appropriateness
|
40 (88.9)
|
23 (51.1)
|
< 0.001
|
Step 1 Empirical therapy
|
44 (97.8)
|
35 (77.8)
|
0.007
|
Appropriate Indication
|
45 (100)
|
45 (100)
|
-
|
Appropriate coverage
|
45 (100)
|
41 (91.1)
|
0.041
|
Appropriate dosage regimen
|
44 (97.8)
|
39 (88.7)
|
0.049
|
Step 2 Documentation therapy
|
40 (88.9)b
|
29 (64.4)
|
0.004
|
Appropriate indication
|
43 (95.6)
|
41 (91.1)
|
0.361
|
Appropriate dosage regimen
|
44 (97.8)
|
43 (93.3)
|
0.242
|
Appropriate duration
|
41 (91.1)
|
34 (75.6)
|
0.039
|
Length of stay (days) (median (IQR))
|
28 (19-42)
|
23 (16-35)
|
0.689
|
30-day infectious diseases related mortality
|
6 (13.6)
|
5 (11.1)
|
1.000
|
Total antibiotic duration (days) (median (IQR))
|
14 (10-23)
|
15 (10-21)
|
0.948
|
antibiotic duration in de-escalation
|
21 (14-28)
|
17.5 (15.5-29.5)
|
0.666
|
antibiotic duration in escalation
|
19 (13-34.5)
|
15 (11-25.5)
|
0.309
|